Charles River Laboratories International operates across three main business segments serving the pharmaceutical and biotechnology industries globally. The Research Models and Services division breeds laboratory animals such as rodents and mice, and provides diagnostic and cell therapy support services for preclinical research. The Discovery and Safety Assessment segment delivers testing and evaluation services for drug candidates, including toxicology studies and laboratory-based screening, while the Manufacturing Solutions segment conducts quality testing of pharmaceuticals and biologics as well as contract manufacturing and development work. The company also maintains research partnerships focused on cancer immunotherapy, vaccine development, and antibody-drug conjugate technologies.

entry readiness 11 · NOT READY · exit proximity 15

Value area 146.20–237.32 · 14% of 120d volume overhead · clean runway